NYSE:GMREGlobal Medical REIT Stock Price, Forecast & News

Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, GMRE shares have decreased by 13.6% and is now trading at $10.72. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Global Medical REIT.

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Global Medical REIT.

Global Medical REIT Inc (NYSE:GMRE) released its earnings results on Wednesday, May, 6th. The company reported $0.03 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.20 by $0.17. The company earned $21.65 million during the quarter, compared to analyst estimates of $21.04 million. Global Medical REIT had a return on equity of 2.58% and a net margin of 11.13%. View Global Medical REIT's earnings history.

Global Medical REIT announced a quarterly dividend on Tuesday, March 3rd. Shareholders of record on Wednesday, March 25th will be paid a dividend of $0.20 per share on Thursday, April 9th. This represents a $0.80 dividend on an annualized basis and a yield of 7.46%. The ex-dividend date is Tuesday, March 24th. View Global Medical REIT's dividend history.

5 brokers have issued 12-month price objectives for Global Medical REIT's stock. Their forecasts range from $12.00 to $17.00. On average, they anticipate Global Medical REIT's stock price to reach $15.10 in the next year. This suggests a possible upside of 40.9% from the stock's current price. View analysts' price targets for Global Medical REIT.

Media coverage about GMRE stock has trended positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Global Medical REIT earned a media sentiment score of 2.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View the latest news aboutGlobal Medical REIT.

Some companies that are related to Global Medical REIT include Easterly Government Properties (DEA), Ryman Hospitality Properties (RHP), Washington Real Estate Investment Trust (WRE), Pebblebrook Hotel Trust (PEB), Caretrust REIT (CTRE), Paramount Group (PGRE), RLJ Lodging Trust (RLJ), Brandywine Realty Trust (BDN), CHIMERA INVT CO/SH NEW (CIM), Uniti Group (UNIT), American Assets Trust (AAT), Four Corners Property Trust (FCPT), Columbia Property Trust (CXP), The GEO Group (GEO) and LTC Properties (LTC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), Insys Therapeutics (INSY), General Electric (GE), Square (SQ), Big Lots (BIG), New Residential Investment (NRZ), Ready Capital (RC), AGNC Investment (AGNC), AT&T (T) and Energy Transfer LP Unit (ET).

(GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Global Medical REIT's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.72%), State Street Corp (2.09%), Wells Fargo & Company MN (1.91%), Geode Capital Management LLC (1.29%), Invesco Ltd. (1.18%) and JPMorgan Chase & Co. (0.89%). Company insiders that own Global Medical REIT stock include Henry Cole, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View institutional ownership trends for Global Medical REIT.

GMRE stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Two Sigma Investments LP, Foundry Partners LLC, Nuveen Asset Management LLC, ClariVest Asset Management LLC, UBS Group AG, Chicago Equity Partners LLC, and WINTON GROUP Ltd. View insider buying and selling activity for Global Medical REIT.

GMRE stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Crown Advisors Management Inc., JPMorgan Chase & Co., Virtus ETF Advisers LLC, Geode Capital Management LLC, Wells Fargo & Company MN, and Wedge Capital Management L L P NC. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Ronald Marston, and Zh Usa, Llc. View insider buying and selling activity for Global Medical REIT.

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GMRE stock can currently be purchased for approximately $10.72.

Global Medical REIT has a market capitalization of $482.51 million and generates $70.73 million in revenue each year. The company earns $9.23 million in net income (profit) each year or $0.75 on an earnings per share basis.

The official website for Global Medical REIT is www.globalmedicalreit.com.

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.